greeksoup/ stock research

QuidelOrtho (QDEL) FY2023 results: revenue $3.0 billion, down 8.2% on the year

QuidelOrtho Corp. (QDEL) reported revenue of $3.0 billion for fiscal 2023, the year ended 31 December 2023, down 8.2% on the year before. Net income was -$10 million, and diluted earnings per share $-0.15. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2024.

Revenue
$3.0 billion
-8.2% on the year
FY2020FY2023
Operating margin
4.6%
25.8% a year earlier
FY2020FY2023
Net income
-$10 million
FY2020FY2023
Diluted EPS
-$0.15
FY2020FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue2,9983,2661,699-8.2%
Cost of revenue1,5031,330420+13.0%
Gross profit1,4941,9361,278-22.8%
Gross margin49.8%59.3%75.3%
Research and development24518895.7+30.4%
Selling, general and administrative763621240+22.9%
Operating income139844906-83.5%
Operating margin4.6%25.8%53.3%
Interest expense14875.7n/a+95.0%
Pre-tax income-29.1736900
Income tax-19.0187196
Effective tax raten/a25.4%21.8%
Net income-10.1549704
Net margin-0.3%16.8%41.5%
Diluted EPS-$0.15$9.56$16.43
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow280885806-68.3%
Capital expenditure209141293+48.5%
Free cash flow70.9744513-90.5%
Free cash flow margin2.4%22.8%30.2%
Cash from investing-188-1,644-320
Cash from financing-266252-173
Depreciation and amortisation45728452.7+61.2%
Share-based compensation51.648.425.4+6.6%
Buybacks7.274.3104-90.3%
Diluted shares, weighted67m57m43m+16.4%
Shares outstanding at period end67m66m42m+0.5%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity5,0064,9351,929+1.4%
Debt2,4232,6490.7-8.5%
Operating lease liabilities173186129-7.3%
Finance lease liabilities0.40.80.7-50.0%
Other liabilities9611,085371-11.4%
Total liabilities and equity8,5638,8562,430-3.3%
Fixed assets1,4441,339349+7.8%
Goodwill2,4922,477337+0.6%
Intangible assets2,9343,12498.7-6.1%
Investments55.873.163.6-23.7%
Cash and equivalents119293803-59.4%
Receivables303454378-33.2%
Inventory578524199+10.2%
Other assets637572202+11.4%
Total assets8,5638,8562,430-3.3%

10-K for the year ended 31 December 2023, filed 29 February 2024: the filing.